Solid, sustainable governance

Honesty, ethics and integrity are bedrock values integral to the Grifols culture. The company's behavior – the way we do business – is tied to our commitment to the United Nations Sustainability Development Goals defined in its 2030 agenda, which strongly reflect human rights principles (see our  Human Rights Policy).

Through its Sustainability Committee, reporting directly to the Board of Directors, Grifols establishes its core environmental, social and governance principals and commitments and ensures the company's sustainability strategies, policies and practices are embraced at all levels of the organization. Further details can be found in our Sustainability Policy.

Doing what is right is constituted in our Code of Ethics and Code of Conduct. These precepts, together with Crime Prevention and Anti-Corruption policies, are central components of the Grifols global compliance program.

Bioethics guide the company's research, development, production and marketing of its products. Grifols only uses plasma from qualified donors to produce its plasma-derived medicines and does so following all relevant regulations.

When pricing our treatments, we follow two core principals. First, cost should never get in the way of patients receiving optimal care and treatment, as highlighted in the Social Return on Investment analysis. Second, pricing should ensure the company's long-term sustainability and reinforce its commitment to researching and developing new therapies.

We have incorporated more than 10 corporate policies into our daily operations. And we annually report a comprehensive review of the company's financial performance and its integration with environmental, social responsibility and corporate governance criteria, as well as our interactions with healthcare professionals and healthcare and patient advocacy organizations worldwide.